• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有或无肝移植病史的冠状动脉旁路移植术(CABG)患者的结局

Outcomes of Coronary Artery Bypass Grafting (CABG) Patients With and Without a History of Liver Transplant.

作者信息

Sodoma Andrej M, Pellegrini James R, Greenberg Samuel, Sodoma Andrej, Munshi Rezwan, Pellegrini Richard G, Singh Jaspreet

机构信息

Internal Medicine, South Shore University Hospital, Bay Shore, USA.

Internal Medicine, Nassau University Medical Center, East Meadow, USA.

出版信息

Cureus. 2024 Dec 16;16(12):e75820. doi: 10.7759/cureus.75820. eCollection 2024 Dec.

DOI:10.7759/cureus.75820
PMID:39822448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11737807/
Abstract

BACKGROUND

Liver transplant (LT) patients face various challenges, including an increased risk of coronary artery disease (CAD) for a variety of reasons, with 70% of LT recipients having one cardiovascular event. Coronary artery bypass grafting (CABG) remains one of the most commonly performed major surgical procedures in the United States, with 20-30% of LT patients requiring a CABG. Many studies have analyzed when to perform a CABG and CAD workup pre-LT, but this population remains a problem. The patient population is challenging to study due to their rarity and complexity. Our study aimed to compile many patients through the National Inpatient Sample (NIS) database to gauge the outcomes of CABG in patients with and without a history of LT.  Methods: Patients who underwent CABG with or without a history of LT were selected from the NIS from 2008 to 2020. The International Classification of Diseases (ICD) 9 and 10 codes were used to identify suitable records. Primary outcomes of interest were all-cause hospital mortality, shock, acute myocardial infarction, acute kidney injury (AKI), and a composite of these. Secondary outcomes included length of stay and total charges.  Results: A weighted total of 2,407,349 CABG hospitalizations were included in this study. Of these, 1,833 had a history of LT. Overall, patients with a history of LT were more likely to be younger (65.16 vs. 66.16; p<0.001), male (81.6% vs. 73.66%; p<0.001), and more complex (Charlson Comorbidity Index (CCI) 5.89 vs. 4.16; p<0.001) than patients without a history of LT. Patients with a history of LT also had higher rates of diabetes mellitus type 2 (57.02% vs. 43.39%; p<0.001), end-stage renal disease (11.21% vs. 2.95%; p<0.001), and gastroesophageal reflux disease (GERD) (28.39% vs. 21.26%; p<0.001). CABG patients with a history of LT were less likely, however, to have hyperlipidemia (56.72% vs. 74.26%; p<0.001), hypertension (25.95% vs. 58.45%; p<0.001), obesity (19% vs. 23.42%; p=0.046), a history of smoking (12.06% vs. 18.66%; p<0.01), or alcohol use disorder (9.04% vs. 13.44%; p=0.017). We found that patients admitted for CABG with a history of LT had significantly higher adjusted odds of mortality (OR 1.84; p<0.01), AKI (OR 2.65; p<0.001), and composite outcome (OR 2.04; p<0.001). They also experienced a longer length of stay (1.7 days; p=0.02) and greater hospital charges ($26,761; p=0.029).

CONCLUSION

We found that CABG patients with a history of LT had nearly twofold higher odds of mortality, nearly threefold higher odds of AKI, and twofold higher odds of composite outcomes than CABG patients without LT. This corresponded to longer lengths of stay and increased hospital charges. Patients should require lower thresholds for left heart catheterization and more strict CAD testing before an LT due to the increased risk of adverse outcomes with the current standard of care.

摘要

背景

肝移植(LT)患者面临各种挑战,包括因多种原因导致的冠状动脉疾病(CAD)风险增加,70%的LT受者会发生一次心血管事件。冠状动脉旁路移植术(CABG)仍然是美国最常进行的主要外科手术之一,20%-30%的LT患者需要进行CABG。许多研究分析了LT前何时进行CABG和CAD检查,但这一人群仍然是个问题。由于其罕见性和复杂性,该患者群体的研究具有挑战性。我们的研究旨在通过国家住院样本(NIS)数据库汇总众多患者,以评估有或无LT病史患者的CABG结局。

方法

从2008年至2020年的NIS中选择有或无LT病史且接受CABG的患者。使用国际疾病分类(ICD)9和10编码来识别合适的记录。感兴趣的主要结局是全因住院死亡率、休克、急性心肌梗死、急性肾损伤(AKI)以及这些情况的综合。次要结局包括住院时间和总费用。

结果

本研究共纳入加权后的2407349例CABG住院患者。其中,1833例有LT病史。总体而言,有LT病史的患者比无LT病史的患者更年轻(65.16岁对66.16岁;p<0.001)、男性比例更高(81.6%对73.66%;p<0.001)且病情更复杂(Charlson合并症指数(CCI)5.89对4.16;p<0.001)。有LT病史的患者2型糖尿病(57.02%对43.39%;p<0.001)、终末期肾病(11.21%对2.95%;p<0.001)和胃食管反流病(GERD)(28.39%对21.26%;p<0.001)的发生率也更高。然而,有LT病史的CABG患者患高脂血症(56.72%对74.26%;p<0.001)、高血压(25.95%对58.45%;p<0.001)、肥胖(19%对23.42%;p=0.046)、吸烟史(12.06%对18.66%;p<0.01)或酒精使用障碍(9.04%对13.44%;p=0.017)的可能性较小。我们发现,因CABG入院且有LT病史的患者调整后的死亡几率(OR 为1.84;p<0.01)、AKI几率(OR 为2.65;p<0.001)和综合结局几率(OR 为2.04;p<0.001)显著更高。他们的住院时间也更长(1.7天;p=0.02),住院费用更高(26761美元;p=0.029)。

结论

我们发现,有LT病史的CABG患者的死亡几率比无LT病史的CABG患者高出近两倍,AKI几率高出近三倍,综合结局几率高出两倍。这与更长的住院时间和更高的住院费用相对应。由于当前护理标准下不良结局风险增加,患者在LT前应降低左心导管插入术的阈值,并进行更严格的CAD检测。

相似文献

1
Outcomes of Coronary Artery Bypass Grafting (CABG) Patients With and Without a History of Liver Transplant.有或无肝移植病史的冠状动脉旁路移植术(CABG)患者的结局
Cureus. 2024 Dec 16;16(12):e75820. doi: 10.7759/cureus.75820. eCollection 2024 Dec.
2
A 13-Year Nationwide Analysis of Nocardia and Actinomyces Infection Outcomes in Liver Transplant Recipients.一项对肝移植受者诺卡菌和放线菌感染结局的13年全国性分析。
Transplant Proc. 2025 May;57(4):670-674. doi: 10.1016/j.transproceed.2025.02.037. Epub 2025 Mar 17.
3
A 13-year nationwide analysis of outcomes of non-variceal upper gastrointestinal bleeding in post-bariatric surgery patients.一项针对减肥手术后患者非静脉曲张性上消化道出血结局的为期13年的全国性分析。
Transl Gastroenterol Hepatol. 2025 Jan 7;10:6. doi: 10.21037/tgh-24-100. eCollection 2025.
4
Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study.冠状动脉旁路移植术与经皮冠状动脉介入治疗后急性肾损伤及院内死亡率:一项全国性研究
Am J Nephrol. 2017;45(3):217-225. doi: 10.1159/000455906. Epub 2017 Jan 31.
5
Cardiovascular Outcomes of Redo-coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention of Index Bypass Grafts Among Acute Coronary Syndrome: Regression Matched National Cohort Study.急性冠状动脉综合征中再次冠状动脉旁路移植术与初次旁路移植血管经皮冠状动脉介入治疗的心血管结局:回归匹配全国队列研究
Curr Probl Cardiol. 2023 May;48(5):101580. doi: 10.1016/j.cpcardiol.2022.101580. Epub 2023 Jan 4.
6
Sex Disparities in In-Hospital Outcomes After Percutaneous Coronary Intervention (PCI) in Patients With Acute Myocardial Infarction and a History of Coronary Artery Bypass Grafting (CABG): A Cross-Sectional Study.急性心肌梗死合并冠状动脉旁路移植术(CABG)病史患者经皮冠状动脉介入治疗(PCI)后院内结局的性别差异:一项横断面研究。
Health Sci Rep. 2024 Dec 19;7(12):e70292. doi: 10.1002/hsr2.70292. eCollection 2024 Dec.
7
Impact of Obesity on Outcome for Inflammatory Bowel Disease Patients From 2008 Through 2020.2008年至2020年肥胖对炎症性肠病患者预后的影响
Cureus. 2024 Oct 5;16(10):e70903. doi: 10.7759/cureus.70903. eCollection 2024 Oct.
8
Acute myocardial infarction-cardiogenic shock in patients with prior coronary artery bypass grafting: A 16-year national cohort analysis of temporal trends, management and outcomes.既往有冠状动脉旁路移植术患者的急性心肌梗死-心源性休克:一项关于时间趋势、管理及结局的16年全国队列分析
Int J Cardiol. 2020 Jul 1;310:9-15. doi: 10.1016/j.ijcard.2020.02.033. Epub 2020 Feb 13.
9
Postoperative acute kidney injury requiring continuous renal replacement therapy and outcomes after coronary artery bypass grafting: a nationwide cohort study.冠状动脉旁路移植术后需要连续肾脏替代治疗的急性肾损伤和结局:一项全国性队列研究。
J Cardiothorac Surg. 2021 Oct 26;16(1):315. doi: 10.1186/s13019-021-01704-7.
10
Outcomes of percutaneous coronary interventions in patients with liver transplant.肝移植患者经皮冠状动脉介入治疗的结果。
Catheter Cardiovasc Interv. 2020 Nov;96(6):E576-E584. doi: 10.1002/ccd.29168. Epub 2020 Jul 29.

本文引用的文献

1
Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation.接受原位肝移植评估患者的心脏科评估
J Soc Cardiovasc Angiogr Interv. 2022 Nov 25;2(1):100528. doi: 10.1016/j.jscai.2022.100528. eCollection 2023 Jan-Feb.
2
Combined Liver Transplant and Cardiac Surgery: Long-term Outcomes and Predictors of Success.肝移植与心脏手术联合:长期预后及成功预测因素
Ann Surg. 2025 May 1;281(5):834-842. doi: 10.1097/SLA.0000000000006171. Epub 2023 Dec 5.
3
Combined coronary artery bypass graft and liver/kidney transplantation in a liver failure patient with acute on chronic kidney failure and antiphospholipid syndrome.在一位合并有抗磷脂综合征的慢性加急性肾衰竭的肝功能衰竭患者中,进行冠状动脉旁路移植术和肝/肾联合移植。
Am J Transplant. 2022 Oct;22(10):2464-2466. doi: 10.1111/ajt.17067. Epub 2022 May 5.
4
Cardiac Intervention Before Liver Transplantation.心脏介入治疗在肝移植前。
Transplant Proc. 2021 Jun;53(5):1622-1625. doi: 10.1016/j.transproceed.2021.03.012. Epub 2021 Apr 21.
5
Outcomes of Surgical Coronary Revascularization Performed Before Solid Abdominal Organ Transplants.实体腹部器官移植术前行冠状动脉旁路移植术的结果。
Ann Thorac Surg. 2021 Feb;111(2):568-575. doi: 10.1016/j.athoracsur.2020.05.077. Epub 2020 Jul 9.
6
Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study.在肝移植候选者中,冠状动脉风险因素、运动能力和单光子发射计算机断层扫描的预后价值:一项 5 年随访研究。
J Nucl Cardiol. 2021 Dec;28(6):2876-2891. doi: 10.1007/s12350-020-02126-z. Epub 2020 May 11.
7
Outcomes in patients with solid organ transplants undergoing cardiac surgery.实体器官移植患者接受心脏手术的结果。
J Thorac Cardiovasc Surg. 2020 Sep;160(3):701-707. doi: 10.1016/j.jtcvs.2019.07.102. Epub 2019 Aug 28.
8
The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation.肝移植前心血管危险因素概况及其对肝移植后长期死亡率的影响。
Ann Transplant. 2018 Aug 21;23:591-597. doi: 10.12659/AOT.908771.
9
Conduits Used in Coronary Artery Bypass Grafting: A Review of Morphological Studies.冠状动脉旁路移植术中使用的血管移植物:形态学研究综述
Ann Thorac Cardiovasc Surg. 2017 Apr 20;23(2):55-65. doi: 10.5761/atcs.ra.16-00178. Epub 2017 Feb 14.
10
Evaluation of coronary artery disease in potential liver transplant recipients.潜在肝移植受者冠状动脉疾病的评估。
Liver Transpl. 2017 Mar;23(3):386-395. doi: 10.1002/lt.24679.